References
- Gu Y, Xu H, Tang D. Mechanism of primary membranous nephropathy. Biomolecules. 2021;11:1. 2021 doi: 10.3390/biom11040513.
- Sasaki K, Yasuda K, Nakanishi K, et al. Membranous nephropathy secondary to graves’ disease with deposits of thyroid peroxidase in an adult. CEN Case Rep. 2014;3(1):90–3. doi: 10.1007/s13730-013-0093-y.
- Sethi S. New antigens in membranous nephropathy. J Am Soc Nephrol. 2021;32(2):268–278. doi: 10.1681/ASN.2020071082.
- Trujillo H, Alonso M, Praga M. New ways of understanding membranous nephropathy. Nephron. 2020;144(6):261–271. doi: 10.1159/000506948.
- Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41(1):91–98. doi: 10.1007/s40618-017-0740-9.
- de Menezes Neves PDM, Rego Muniz MP, Morgantetti GF, et al. Membranous nephropathy secondary to graves’ disease: a case report. Front Immunol. 2022;13:824124. doi: 10.3389/fimmu.2022.824124.